Aggregation-defective α-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked α-synuclein variants

被引：19

作者：

Koo, Hyun-Jung ^{[1
]}

Choi, Min Yeong ^{[1
]}

Im, Hana ^{[1
]}

机构：

[1] Sejong Univ, Dept Mol Biol, Seoul 143747, South Korea

来源：

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2009年 / 386卷 / 01期

关键词：

Conformational switch; Protein amyloid; Protein fibrils; Protein folding; alpha-Synuclein; ALZHEIMERS-DISEASE; BETA-SHEET; MUTATION; FIBRILS; E46K; NEURODEGENERATION; FIBRILLOGENESIS; FIBRILLIZATION; PATHOGENESIS; DUPLICATION;

D O I：

10.1016/j.bbrc.2009.06.002

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

alpha-Synuclein comprises the fibrillar core of Lewy bodies, which is one of the histologically defining lesions of Parkinson's disease. Previously, we screened for alpha-synuclein substitution mutants that do not form fibrils. For preventative or therapeutic uses, it is essential to suppress the oligomerization/fibrillation of the wild-type and PD-linked alpha-synuclein proteins. Here we have examined the effects of fibrillation-retarded alpha-synuclein mutants on fibril formation by wild-type and PD-linked alpha-synuclein molecules. Six self-aggregation-defective alpha-synuclein mutants completely inhibit the fibrillation of both wild-type and Parkinson's disease-linked of alpha-synuclein variants. These results suggest future applications for gene therapy: the transplantation of a fibrillation-blocking mutant alpha-synuclein gene into individuals who carry an early-onset PD-associated alpha-synuclein allele. Short synthetic peptides derived from these mutant sequences may also serve as a lead compound for the development of therapeutics for Parkinson's disease. (C) 2009 Elsevier Inc. All rights reserved.

引用

页码：165 / 169

页数：5

共 29 条

[11] Causal relation between α-synuclein gene duplication and familial Parkinson's disease [J].

Ibáñez, P ;

Bonnet, AM ;

Débarges, B ;

Lohmann, E ;

Tison, F ;

Pollak, P ;

Agid, Y ;

Dürr, A ;

Brice, A .

LANCET, 2004, 364 (9440) :1169-1171

[12] Alternative conformations of amyloidogenic proteins govern their behavior [J].

Kelly, JW .

CURRENT OPINION IN STRUCTURAL BIOLOGY, 1996, 6 (01) :11-17

[13] The N-terminal repeat domain of α-synuclein inhibits β-sheet and amyloid fibril formation [J].

Kessler, JC ;

Rochet, JC ;

Lansbury, PT .

BIOCHEMISTRY, 2003, 42 (03) :672-678

[14] Amyloid diseases: Abnormal protein aggregation in neurodegeneration [J].

Koo, EH ;

Lansbury, PT ;

Kelly, JW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) :9989-9990

[15] Sequence determinants regulating fibrillation of human α-synuclein [J].

Koo, Hyun-Jung ;

Lee, Hak-Joo ;

Im, Hana .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 368 (03) :772-778

[16] Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease [J].

Krüger, R ;

Kuhn, W ;

Müller, T ;

Woitalla, D ;

Graeber, M ;

Kösel, S ;

Przuntek, H ;

Epplen, JT ;

Schöls, L ;

Riess, O .

NATURE GENETICS, 1998, 18 (02) :106-108

[17] Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders [J].

Masliah, E ;

Rockenstein, E ;

Veinbergs, I ;

Mallory, M ;

Hashimoto, M ;

Takeda, A ;

Sagara, Y ;

Sisk, A ;

Mucke, L .

SCIENCE, 2000, 287 (5456) :1265-1269

[18] Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for α-synuclein fibrils in vitro [J].

Ono, K ;

Yamada, M .

JOURNAL OF NEUROCHEMISTRY, 2006, 97 (01) :105-115

[19] The alpha-synuclein mutation E46K promotes aggregation in cultured cells [J].

Pandey, N ;

Schmidt, RE ;

Galvin, JE .

EXPERIMENTAL NEUROLOGY, 2006, 197 (02) :515-520

[20] Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a β-sheet breaker peptide [J].

Permanne, B ;

Adessi, C ;

Saborio, GP ;

Fraga, S ;

Frossard, MJ ;

Van Dorpe, J ;

Dewachter, I ;

Banks, WA ;

Van Leuven, F ;

Soto, C .

FASEB JOURNAL, 2002, 16 (06) :860-+

← 1 2 3 →